Identification of a novel risk variant in the FUS gene in essential tremor
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: A nonsense mutation in the amyotrophic lateral sclerosis gene FUS has been found to segregate in a large family with essential tremor (ET). Coding variants in this gene have not been comprehensively evaluated in ET. We conducted a genetic analysis of FUS for pathogenic and novel coding variants in 2 case-control cohorts among ethnic Chinese.
Methods: In a study that involved 7,548 subjects, we first sequenced all the exon and exon-intronic boundaries of FUS in 84 ET samples. Potential causative variants that were identified were then genotyped in 2 separate case-control cohorts involving 263 additional ET samples and 5,919 controls (set 1) and 250 ET cases and 250 controls (set 2), and 782 diseased controls of Chinese ethnicity from 2 different Asian countries.
Results: We identified a novel variant, Met392Ile, in exon 12 of the FUS gene. This variant was associated with ET in set 1 (odds ratio = 4.72 [95% confidence interval = 1.90–11.71], p = 0.0037). The association was subsequently validated in set 2 (joint analysis odds ratio = 3.92 [95% confidence interval = 1.57–9.82], p = 8.6 × 10−4). No association was observed in another neurologic cohort of patients with Parkinson disease, and no other potential pathogenic mutations were identified.
Conclusion: We identified a novel risk variant, Met392Ile, in the FUS gene that increases susceptibility of ET among ethnic Chinese. Further studies in other ethnic populations are needed to determine whether this is an ethnic-specific risk factor.
GLOSSARY
- ALS=
- amyotrophic lateral sclerosis;
- CI=
- confidence interval;
- ET=
- essential tremor;
- FUS=
- fused in sarcoma;
- mRNA=
- messenger RNA;
- OR=
- odds ratio;
- PD=
- Parkinson disease;
- SNP=
- single nucleotide polymorphism;
- TLS=
- translated in liposarcoma
Footnotes
↵* These authors contributed equally as first authors.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
- Received February 26, 2013.
- Accepted in final form April 25, 2013.
- © 2013 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Author response
- Eng-King Tan, Singapore General Hospital, tan.eng.king@sgh.com.sg
- Yih-Ru Wu, Chang Gung Memorial Hospital, Taipei, Taiwan
Submitted September 24, 2013 - Replication needed!
- Gregor Kuhlenbaeumer, Group leader, University of Kiel, Dept. of Neurologyg.kuhlenbaeumer@neurologie.uni-kiel.de
Submitted July 24, 2013
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutationsA. S. Chen-Plotkin, W. Yuan, C. Anderson et al.Neurology, October 03, 2007 -
Views & Reviews
Genetics of essential tremorMeta-analysis and reviewGregor Kuhlenbäumer, Franziska Hopfner, Günther Deuschl et al.Neurology, February 14, 2014 -
Article
Identification of TYW3/CRYZ and FGD4 as susceptibility genes for amyotrophic lateral sclerosisLing Wei, Yanghua Tian, Yongping Chen et al.Neurology: Genetics, November 08, 2019 -
Articles
LRRK2 gene in Parkinson diseaseMutation analysis and case control association studyC. Paisán-Ruíz, A. E. Lang, T. Kawarai et al.Neurology, June 15, 2005